UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 167

Sortiert nach

Economic Analysis of Vinorelbine Plus Cisplatin Versus Paclitaxel Plus Carboplatin for Advanced Non-Small-Cell Lung Cancer

JNCI : Journal of the National Cancer Institute, 2002-02, Vol.94 (4), p.291-297

2002

Volltextzugriff (PDF)

EE97 Population Discordance in Economic Evaluations of Polygenic Risk Scores

Value in health, 2022-07, Vol.25 (7), p.S353-S354

2022

Volltextzugriff (PDF)

Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability

JNCI : Journal of the National Cancer Institute, 2004-02, Vol.96 (4), p.261-268

2004

Volltextzugriff (PDF)

EE5 Assessment of Value Based Price (VBP) for a Multi-Cancer Early Detection (MCED) Test in a Medicare Population

Value in health, 2022-07, Vol.25 (7), p.S335-S336

2022

Volltextzugriff (PDF)

POSB44 Drivers of Value-Based Price (VBP) for a Multi-Cancer Early Detection (MCED) Test

Value in health, 2022-01, Vol.25 (1), p.S68-S68

2022

Volltextzugriff (PDF)

Why do men choose one treatment over another? : A review of patient decision making for localized prostate cancer

Cancer, 2006-05, Vol.106 (9), p.1865-1874

2006

Volltextzugriff (PDF)

A landscape analysis and discussion of value of gene therapies for sickle cell disease

Expert review of pharmacoeconomics & outcomes research, 2022-08, Vol.22 (6), p.891-911

2022

Volltextzugriff (PDF)

Randomized Phase III Trial of Paclitaxel Plus Carboplatin Versus Vinorelbine Plus Cisplatin in the Treatment of Patients With Advanced Non–Small-Cell Lung Cancer: A Southwest Oncology Group Trial

Journal of clinical oncology, 2001-07, Vol.19 (13), p.3210-3218

2001

Volltextzugriff (PDF)

The Economic Burden of COPD

Chest, 2000-02, Vol.117 (2), p.5S-9S

2000

Volltextzugriff (PDF)

Incidence, outcomes, and cost of foot ulcers in patients with diabetes

Diabetes care, 1999-03, Vol.22 (3), p.382

1999

Volltextzugriff (PDF)

Abstract P6-12-09: Association between cardiovascular risk factors and cardiac events among breast cancer patients enrolled in SWOG clinical trials

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.P6-P6-12-09

2018

Volltextzugriff (PDF)

PRM126 - A COMPARISON OF MIXTURE CURE AND STANDARD PARAMETRIC MODELING TO ESTIMATE LONG-TERM SURVIVAL FOR SMALL-CELL LUNG CANCER IN PATIENTS TREATED WITH NIVOLUMAB AFTER PROGRESSION

Value in health, 2018-10, Vol.21, p.S377-S377

2018

Volltextzugriff (PDF)

Cost Effectiveness of Lung-Volume–Reduction Surgery for Patients with Severe Emphysema

The New England journal of medicine, 2003-05, Vol.348 (21), p.2092-2102

2003

Volltextzugriff (PDF)

Effect of improved glycemic control on health care costs and utilization

JAMA : the journal of the American Medical Association, 2001-01, Vol.285 (2), p.182

2001

Volltextzugriff (PDF)

Breast Cancer in Limited-Resource Countries: An Overview of the Breast Health Global Initiative 2005 Guidelines

The breast journal, 2006-01, Vol.12 (s1), p.S3-S15

2006

Volltextzugriff (PDF)

Observational Study Designs for Comparative Effectiveness Research: An Alternative Approach to Close Evidence Gaps in Head-and-Neck Cancer

International journal of radiation oncology, biology, physics, 2014, Vol.88 (1), p.106-114

2014

Volltextzugriff (PDF)

The Effect of Lung Volume Reduction Surgery on Chronic Obstructive Pulmonary Disease Exacerbations

American journal of respiratory and critical care medicine, 2008-01, Vol.177 (2), p.164-169

2008

Volltextzugriff (PDF)

Quality of life in survivors of colorectal carcinoma

Cancer, 2000-03, Vol.88 (6), p.1294-1303

2000

Volltextzugriff (PDF)

Polypharmacy and out-of-pocket medication costs in the last month of life among commercially insured patients with advanced cancer: Insights from linking a regional cancer registry and insurance claims

Journal of clinical oncology, 2017, Vol.35 (31_suppl), p.79-79

2017

Volltextzugriff (PDF)

Does Economics Matter When Treating Advanced Non‐Small Cell Lung Cancer?

The oncologist (Dayton, Ohio), 2002-01, Vol.7 (3), p.179-180

2002

Volltextzugriff (PDF)

Quality of life in long term survivors of colorectal cancer

The American journal of gastroenterology, 2002-05, Vol.97 (5), p.1228-1234

2002

Volltextzugriff (PDF)

TREATMENT PATTERNS AND PREDICTORS FOR OVERALL SURVIVAL IN PATIENTS WITH METASTATIC MERKEL CELL CARCINOMA IN THE UNITED STATES

Value in health, 2017-05, Vol.20 (5), p.A3

2017

Volltextzugriff (PDF)

TREATMENT PATTERNS AND TOTAL HEALTHCARE COSTS OF METASTATIC MERKEL CELL CARCINOMA IN THE UNITED STATES

Value in health, 2017-05, Vol.20 (5), p.A157

2017

Volltextzugriff (PDF)

Cost-Effectiveness of Unrelated Umbilical Cord Blood vs. HLA Haploidentical Related Bone Marrow Transplant: Evidence from BMT CTN 1101

Transplantation and cellular therapy, 2023-04, Vol.29 (7), p.464.e1-464.e8

2023

Volltextzugriff (PDF)

Breast Cancer in Limited-Resource Countries: Health Care Systems and Public Policy

The breast journal, 2006-01, Vol.12 (s1), p.S54-S69

2006

Volltextzugriff (PDF)

1 – 25 von 167

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(158)
Mit Volltextzugriff
(149)

Publikationsform

Sprache

Englisch
(167)
Japanisch
(23)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Value In Health
(36)
Physics Of Plasmas
(9)
Medical Care
(6)
Physical Review Letters
(5)
Physics Of Fluids. B, Plasma Physics
(5)
The American Journal Of Managed Care
(5)
Chest
(4)
Cancer
(3)
Genetics In Medicine
(3)
Medical Decision Making
(3)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Economic Analysis of Vinorelbine Plus Cisplatin Versus Paclitaxel Plus Carboplatin for Advanced Non-Small-Cell Lung Cancer

EE97 Population Discordance in Economic Evaluations of Polygenic Risk Scores

Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability

EE5 Assessment of Value Based Price (VBP) for a Multi-Cancer Early Detection (MCED) Test in a Medicare Population

POSB44 Drivers of Value-Based Price (VBP) for a Multi-Cancer Early Detection (MCED) Test

Why do men choose one treatment over another? : A review of patient decision making for localized prostate cancer

A landscape analysis and discussion of value of gene therapies for sickle cell disease

Randomized Phase III Trial of Paclitaxel Plus Carboplatin Versus Vinorelbine Plus Cisplatin in the Treatment of Patients With Advanced Non–Small-Cell Lung Cancer: A Southwest Oncology Group Trial

The Economic Burden of COPD

Incidence, outcomes, and cost of foot ulcers in patients with diabetes

Abstract P6-12-09: Association between cardiovascular risk factors and cardiac events among breast cancer patients enrolled in SWOG clinical trials

PRM126 - A COMPARISON OF MIXTURE CURE AND STANDARD PARAMETRIC MODELING TO ESTIMATE LONG-TERM SURVIVAL FOR SMALL-CELL LUNG CANCER IN PATIENTS TREATED WITH NIVOLUMAB AFTER PROGRESSION

Cost Effectiveness of Lung-Volume–Reduction Surgery for Patients with Severe Emphysema

Effect of improved glycemic control on health care costs and utilization

Breast Cancer in Limited-Resource Countries: An Overview of the Breast Health Global Initiative 2005 Guidelines

Observational Study Designs for Comparative Effectiveness Research: An Alternative Approach to Close Evidence Gaps in Head-and-Neck Cancer

The Effect of Lung Volume Reduction Surgery on Chronic Obstructive Pulmonary Disease Exacerbations

Quality of life in survivors of colorectal carcinoma

Polypharmacy and out-of-pocket medication costs in the last month of life among commercially insured patients with advanced cancer: Insights from linking a regional cancer registry and insurance claims

Does Economics Matter When Treating Advanced Non‐Small Cell Lung Cancer?

Quality of life in long term survivors of colorectal cancer

TREATMENT PATTERNS AND PREDICTORS FOR OVERALL SURVIVAL IN PATIENTS WITH METASTATIC MERKEL CELL CARCINOMA IN THE UNITED STATES

TREATMENT PATTERNS AND TOTAL HEALTHCARE COSTS OF METASTATIC MERKEL CELL CARCINOMA IN THE UNITED STATES

Cost-Effectiveness of Unrelated Umbilical Cord Blood vs. HLA Haploidentical Related Bone Marrow Transplant: Evidence from BMT CTN 1101

Breast Cancer in Limited-Resource Countries: Health Care Systems and Public Policy

Suchergebnisse filtern